Atossa Therapeutics (ATOS) SEC Filings & 10K Form $0.89 -0.03 (-3.13%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$0.87 -0.01 (-1.41%) As of 06/10/2025 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Recent Atossa Therapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView05/22/20255:27 PMAtossa Therapeutics (Issuer)QUAY STEVEN C (Reporting)Form 4Statement of changes in beneficial ownership of securities 05/13/20257:05 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/13/20257:15 AMAtossa Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 03/26/20253:40 PMAtossa Therapeutics (Filer)Form ARS03/26/20253:30 PMAtossa Therapeutics (Filer)Form DEF 14A03/25/20257:05 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/25/20257:10 AMAtossa Therapeutics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/12/20258:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/24/20253:05 PMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 02/07/20253:09 PMAtossa Therapeutics (Subject)CVI Investments, Inc. (Filed by)Form SCHEDULE 13G/A02/04/20258:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/10/20248:05 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/12/202412:32 PMAtossa Therapeutics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/04/202410:27 AMAtossa Therapeutics (Subject)VANGUARD GROUP INC (Filed by)Form SC 13G/A11/04/20245:35 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 10/22/20242:24 PMAtossa Therapeutics (Subject)BlackRock, Inc. (Filed by)Form SC 13G08/12/20248:00 AMAtossa Therapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 08/12/20248:05 AMAtossa Therapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) (Data available from 1/1/2016 forward) Related Companies and Tools Related Companies PureTech Health 10Q Form Septerna 10Q Form Oruka Therapeutics 10Q Form Tourmaline Bio 10Q Form MBX Biosciences 10Q Form MeiraGTx 10Q Form SIGA Technologies 10Q Form Zhengye Biotechnology 10Q Form Upexi 10Q Form Altimmune 10Q Form SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NASDAQ:ATOS) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Atossa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Atossa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
